Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
11.49
-0.86 (-6.93%)
At close: Jun 5, 2026, 4:00 PM EDT
11.49
+0.01 (0.04%)
After-hours: Jun 5, 2026, 4:04 PM EDT
Contineum Therapeutics Employees
Contineum Therapeutics had 51 employees as of December 31, 2025. The number of employees increased by 10 or 24.39% compared to the previous year.
Employees
51
Change (1Y)
10
Growth (1Y)
24.39%
Revenue / Employee
n/a
Profits / Employee
-$1,145,961
Market Cap
429.57M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 51 | 10 | 24.39% |
| Dec 31, 2024 | 41 | 10 | 32.26% |
| Dec 31, 2023 | 31 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| 4D Molecular Therapeutics | 196 |
| Sutro Biopharma | 133 |
| Neurogene | 131 |
| Ocugen | 116 |
| C4 Therapeutics | 104 |
| Editas Medicine | 87 |
| Rezolute | 68 |
| Eupraxia Pharmaceuticals | 49 |
CTNM News
- 6 days ago - Contineum Therapeutics to Present at the 2026 Goldman Sachs Global Healthcare Conference - Business Wire
- 19 days ago - Contineum Therapeutics Transcript: RBC Capital Markets Global Healthcare Conference 2026 - Transcripts
- 23 days ago - Contineum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 24 days ago - Contineum price target raised to $16 from $14 at Morgan Stanley - TheFly
- 26 days ago - Contineum Therapeutics to Present at the 2026 RBC Capital Markets Global Healthcare Conference - Business Wire
- 27 days ago - Contineum Therapeutics Announces Two Upcoming Posters at the American Thoracic Society (ATS) 2026 International Conference - Business Wire
- 4 weeks ago - Contineum Therapeutics Reports First-Quarter 2026 Financial Results; Affirms Key Clinical Development Milestones - Business Wire
- 4 weeks ago - Contineum Therapeutics Earnings release: Q1 2026 - Filings